Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies
Abstract Background/Objectives: Diabetes mellitus is a growing global health concern, driving the exploration of new therapies like cannabidiol (CBD), which…
insulin sensitivity
The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management
Abstract Disorders of the metabolism, including obesity and type 2 diabetes, represent significant global health challenges due to their rising…
The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity
Abstract Background: Cannabinoid type-1 (CB1) receptor inverse agonists improve type 2 diabetes and dyslipidaemia but were discontinued due to adverse…